Skip to main content

Find Clinical Trials

Home
Conditions
Carcinoma, Bronchogenic

Clinical trial condition

Carcinoma, Bronchogenic

Explore clinical trials studying Carcinoma, Bronchogenic. Study availability and eligibility vary by location and protocol.

5,277 public trials 1,202 recruiting studies

Refine in advanced search Browse all conditions

Carcinoma, Bronchogenic trial results

Not yet recruiting

Management Strategy of 1L Lorlatinib With Hyperlipidemia in Stage IIIB-IV ALK Positive NSCLC

NCT07674524

Conditions: ALK Gene Mutation, ALK-positive, Bronchial Neoplasms, +16 more
Locations: Sun Yat-sen University Cancer Center Guangzhou, Guangdong, China

View Trial Details

Not yet recruiting

A Study of SYS6010 Plus Anti-PD-(L)-1 Monoclonal Antibody as Adjuvant Therapy in Non-small Cell Lung Cancer (NSCLC)

NCT07672223

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations: Not specified

View Trial Details

Not yet recruiting

Epigenomic Profiling of Circulating Cell-Free DNA (cfDNA) to Characterize the Dynamic Evolution of Molecular Subtypes in Extensive-Stage Small Cell Lung Cancer During First-Line Chemoimmunotherapy

NCT07670442

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Lung Diseases, +8 more
Locations: Not specified

View Trial Details

Not yet recruiting

Bright Light Therapy in Patients With Melanoma or Non-small Cell Lung Cancer (NSCLC) Who Are Receiving First-Line Immune Checkpoint Blockade

NCT07661966

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +19 more
Locations: Weill Cornell Medicine New York, United States

View Trial Details

Not yet recruiting

A Study to Learn About the Study Medicine Called Ponsegromab in Adults With Lung Cancer-Associated Significant Weight Loss

NCT07663630

Conditions: Anorexia, Body Weight, Body Weight Changes, +18 more
Locations: Not specified

View Trial Details

Not yet recruiting

ITTACA (Immunotherapy Time Teller for Advanced Lung Cancer)

NCT07661251

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations: Not specified

View Trial Details

Not yet recruiting

Photoimmunotherapy With ASP-1929 and Cemiplimab for the Treatment of Refractory, Inoperable, and Metastatic Stage IIIB-IV Non-small Cell Lung Cancer

NCT06943664

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +13 more
Locations: Roswell Park Cancer Institute Buffalo, New York, United States

View Trial Details

Not yet recruiting

A Prospective Study of Firmonertinib as First-line Adaptive Therapy Guided by Dynamic ctDNA (MRD) Changes in Locally Advanced or Metastatic EGFR-mutated Non-small Cell Lung Cancer

NCT07661173

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations: Anhui Provincial Cancer Hospital Hefei, Anhui, China

View Trial Details

Not yet recruiting

Evaluation of the Value of [68Ga]Ga-PENTIXAFOR PET-CT in Patients With Metastatic Small Cell Lung Cancer (SCLC)

NCT07007325

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Lung Diseases, +8 more
Locations: Institut de cancérologie de l'ouest Angers, France

CHU d'Angers Angers, France

Institut de cancérologie de l'ouest Saint-Herblain, France

View Trial Details

Not yet recruiting

A Study of CLSP 5282 in HLA-A*03:01 Positive Adult Patients With Solid Tumors (SENTINEL-101)

NCT07650357

Conditions: Advanced Solid Tumor, Bronchial Neoplasms, Carcinoma, Bronchogenic, +24 more
Locations: Duke Cancer Institute Durham, North Carolina, United States

Thomas Jefferson University, Sidney Kimmel Cancer Center Philadelphia, Pennsylvania, United States

Sarah Cannon Research Institute (SCRI) Oncology Partners Nashville, Tennessee, United States

Mary Crowley Cancer Research Dallas, Texas, United States

View Trial Details